Kesimpta (ofatumumab)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Kesimpta (ofatumumab), covering 2026-03-30 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation [Phase 4]